# Research Study for Patients With Metastatic Renal Cell Carcinoma

> **NCT00110344** · PHASE2 · TERMINATED · sponsor: **Bayer** · enrollment: 1 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

- **DRUG:** Nexavar (Sorafenib, BAY43-9006)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00110344
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2013-10-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110344, "Research Study for Patients With Metastatic Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00110344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*